No association between the HLA-A2 allele and Alzheimer disease

Neurogenetics

Volumn 2, Issue 3, 1999, Pages 177-182

  Small, Gary W ^a,b,c,h   Scott, William K ^d   Komo, Scott ^a,b   Yamaoka, Larry H ⁱ   Farrer, Lindsay A ^f   Auerbach, Sanford H ^f   Saunders, Ann M ^d   Roses, Allen D ^d,e   Haines, Jonathan L ^g   Pericak Vance, Margaret A ^d  

^a Alzheimer's Disease Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

^f BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NONE

Author keywords

Alzheimer disease; Apolipoprotein E; HLA

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HETEROZYGOSITY; HLA SYSTEM; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HLA-A2 ANTIGEN; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED;

EID: 0032849038     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480050080     Document Type: Article

References (54)

1. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42:115-119
2. Brayne C, Gill C, Huppert FA, et al (1995) Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br J Psychiatry 167:255-262
3. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA, Tune LE (1997) Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278:1363-1371
4. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Want K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977
5. Rogaev EI, Sherrington R, Rogaeva EA, et al (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778
6. Sherrington R, Rogaev EI, Liang Y, Rogaev EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760
7. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706
8. Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LH, Hung W-Y, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NL, Heyman A, Clark CM, Roses AD (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48:1034-1050
9. Alzheimer's Disease Collaborative Group (1993) Apolipoprotein E genotype and Alzheimer's disease. Lancet 342:737-738
10. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang M-X, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 34:752-754
11. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele E4 with late onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell P, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
13. Corder EH, Saunders AM, Risch MJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Apolipoprotein E type 2 allele and the risk of late onset Alzheimer's disease. Nat Genet 7:180-183
14. Mayeux R, Saunders AM, Shea S, et al (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 338:506-511
15. Roses AD, Devlin B, Conneally PM, et al (1995) Measuring the genetic contribution of APOE in late-onset Alzheimer disease (AD). Am J Hum Genet 57 [Suppl]:A202
16. Parham P, Ohta T (1996) Population biology of antigen presentation by MHC class I molecules. Science 272:67-74
17. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218
18. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7:84-92
19. Tooyama I, Kimura H, Akiyama H, McGeer PL (1990) Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer disease. Brain Res 523:273-280
20. Mackenzie IR, Hao C, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16:797-804
21. Breitner JCS (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol Aging 17:789-794
22. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-432
23. Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632
24. Spence MA, Heyman A, Marazita ML, Sparkes RS, Weinberg T (1986) Genetic linkage studies in Alzheimer's disease. Neurology 36:581-584
25. Collins JS, Perry RT, Watson, B, Bassett SS, Meyers DA, Albert MS, Tanzi R, Rodes L, Haines JL, Blacker D, Go RCP (1997) Searching for a chromosome 6 association with late onset Alzheimer disease. Soc Neurosci Abstr A381
26. Henschke PJ, Bell DA, Cape RDT (1978) Alzheimer's disease and HLA. Tissue Antigens 12:132-135
27. Sulkava R, Koskimies S, Wikstrom J, Palo J (1980) HLA antigens in Alzheimer's disease. Tissue Antigens 16:191-194
28. Whalley LJ, Urbaniak SJ, Darg C, Peutherer JF, Christie JE (1980) Histocompatibility antigens and antibodies to viral and other antigens in Alzheimer pre-senile dementia. Acta Psychiatr Scand 61:1-7
29. Wilcox CB, Caspary EA, Behan PO (1980) Histocompatibility antigens in Alzheimer's disease. Eur Neurol 19:262-265
30. Snowden PR, Woodrow JC, Copeland JRM (1981) HLA antigens in senile dementia and multiple infarct dementia. Age Ageing 10:259-263
31. Reed E. Thompson D, Mayeux R, Sicui-Foca N (1983) HLA antigens in Alzheimer's disease. Tissue Antigens 21:164-167
32. Reisner E, Heyman A, Weinberg T, Dawson D, Ciftan E (1983) Lack of association between Alzheimer's disease and histocompatibility antigens. Tissue Antigens 21:31-34
33. Renvoize EB (1984) An HLA and family study of Alzheimer's disease. Psychol Med 14:515-520
34. Endo H, Yamamoto T, Kuzuya F (1986) HLA system in senile dementia of Alzheimer type and multi-infarct dementia in Japan. Arch Gerontol Geriatr 5:51-56
35. Small GW, Ebeling SC, Matsuyama SS, Heyman A, Reisner EG, Renvoize EB, Sulkava R (1991) Variable association of HLA-A2 in men with early-onset Alzheimer disease. Neurobiol Aging 12:375-377
36. Small GW, Matsuyama SS (1986) HLA-A2 as a possible marker for early onset Alzheimer disease in men. Neurobiol Aging 7:211-214
37. Payami H, Kaye J, Becker W, Norman D, Wetzsteon P (1991) HLA-A2, or a closely linked gene, confers susceptibility to early onset sporadic Alzheimer's disease in men. Neurology 41:1544-1548
38. Payami H, Schellenberg GD, Zareparsi S, Kaye J, Sexton GJ, Head MA, Matsuyama SS, Jarvik LF, Miller B, McManus DQ, Bird TD, Katzman R, Heston L, Norman D, Small GW (1997) Evidence for association of the major histocompatibility complex allele A2 with onset age of Alzheimer disease. Neurology 49:512-518
39. Combarros O, Escribano J, Sanchez-Velasco P, Leyva-Cobian F, Oterino A, Leno C, Berciano J (1998) Association of the HLA-A2 allele with an ealier age of onset of Alzheimer's disease. Acta Neurol Scand 98:140-141
40. Thomson G (1994) Identifying complex disease genes: progress and paradigms. Nat Genet 8:108-110
41. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
42. Hixson JE, Vernier DR (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31:545-548
43. Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159
44. Fernandez-Vena MA, Falco M, Sun Y, Statsney P (1992) DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol 33:163-173
45. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL (1995) Apolipoprotein E, survival in Alzheimer's disease, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-1328
46. Sobel E, Louhija J, Sulkava R, et al (1995) Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 45:903-907
47. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE-4-associated Alzheimer's disease risk is modified by α 1-antichymotrypsin polymorphism. Nat Genet 10:486-488
48. Okuizumi K, Onodera O, Namba Y, Kobayashi H, Tsuji S, Takahashi H, Oyanag K, Seki K, Tanaka M, Naruse S, et al (1995) Genetic association of very low density lipoprotein (VLDL) receptor gene locus with sporadic Alzheimer's disease. Nat Genet 11:207-209
49. Wragg M, Hutton M, Talbot C, and the Alzheimer's Disease Collaborative Group (1996) Genetic association between intronic polymorphism in presenilin-1- gene and late-onset Alzheimer's disease. Lancet 347:509-512
50. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growden JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA (1996) No genetic effect of α1-antichymotrypsin in Alzheimer disease. Genomics 33:53
51. Pritchard ML, Saunders AM, Gaskell PC, Small GW, Conneally PM, Rosi B, Yamaoka LH, Roses AD, Haines JL, Pericak-Vance MA (1996) No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209:105-108
52. Scott WK, Yamaoka LH, Locke PA, Rosi BL, Gaskell PC, Saunders AM, Conneally PM, Small GW, Farrer LA, Growdon JH, Roses AD, Pericak-Vance MA, Haines JL (1997) No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genet Epidemiol 14:307-315
53. Muller U, Bodeker RH, Gerundt I, Kurz A (1996) Lack of association between alpha-1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon-4 of apolipoprotein E. Neurology 47:1575-1577
54. Okuizumi K, Onodera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders AM, Pericak-Vance MA, Roses AD, Tsuji S (1996) Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's disease. Ann Neurol 40:251-25